Xolair (omalizumab) is a brand-name subcutaneous injection that’s prescribed for hives, asthma, and other conditions. This article covers topics such as side effects, dosage, and how Xolair works.

The recommended Xolair dosage (subcutaneous injection) for the treatment of food allergy is 75-600 mg, once every two or four weeks. Roche has a collaboration agreement with fellow Swiss pharma ...

Kashiv Biosciences is currently developing subcutaneous and intravenous formulations of the injection ... a biosimilar to Xolair. The study enrolled 600 subjects worldwide and aims to assess ...

Xolair (omalizumab ... which is available in markets in the US and EU as a subcutaneous injection lasting a few minutes, instead of a lengthy infusion. Sandra Horning, chief medical officer ...